Like you I'm struggling to see where profits would come from next year. They've got nothing to sell for several years. Maybe BP (I think that's where this figure came from) are assuming some sort of partnership payments and calling that a profit? Whatever I think it's misleading.
I want $10 per share! (If it enhances the performance of mainstream drugs to the level indicated, that's fair value)
Like you I'm struggling to see where profits would come from...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)